Pediatrics: Renal and Adrenal Oncology: Difference between revisions

Line 206: Line 206:


=== Genetics ===
=== Genetics ===
* '''Majority arise from somatic mutations''' restricted to tumor tissue; '''much smaller percentage originate from germline mutations'''
* '''<span style="color:#ff0000">Majority arise from somatic mutations</span>''' restricted to tumor tissue; '''much smaller percentage originate from germline mutations'''
*'''Genes identified as having a role in the development of Wilms tumor (4): WT1''', 11p15, WTX, CTNNB1, TP53
*'''Genes identified as having a role in the development of Wilms tumor (4): WT1''', 11p15, WTX, CTNNB1, TP53
** '''WT1'''
** '''WT1'''
Line 215: Line 215:
****'''Predispose patients to renal insufficiency'''
****'''Predispose patients to renal insufficiency'''
** '''WT1 mutations'''  
** '''WT1 mutations'''  
* '''Syndromes associated with Wilms tumours (4): B.W.’s Dick Feels Warm'''
* '''<span style="color:#ff0000">Syndromes associated with Wilms tumours (4):</span><span style="color:#0000ff"> B.W.’s Dick Feels Warm'''
*#'''Beckwith-Weideman'''
*#'''<span style="color:#ff0000">Beckwith-Weideman'''
*#'''Denys Drash'''
*#'''<span style="color:#ff0000">Denys Drash'''
*#'''Frasier'''
*#'''<span style="color:#ff0000">Frasier'''
*#'''WAGR'''
*#'''<span style="color:#ff0000">WAGR'''


{| class="wikitable"
{| class="wikitable"